Mkts

Veracyte, Inc.

NASDAQ: VCYT
$25.57+1.34 (+5.53%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
24.1725.65
52-week range
21.9160.91
Today
Open24.23
Previous close25.57
Volume—
Valuation
Market cap1.88B
P/E ratio16.42×
EPS (TTM)1.40
Income & risk
Dividend / yield—
Beta2.15
Avg volume1.69M
Discussion

VCYT News

Stories mentioning VCYT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue139,071140,636131,872130,164114,473118,632115,860114,428
Cost of Goods Sold
Gross Profit101,159101,97391,28289,76979,50878,75479,01077,913
Operating Expenses
Research & Development27,09820,84915,98116,26417,72019,29017,57416,465
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)22,64637,19522,946(5,268)2,9044,17512,0174,606
Interest Income
Interest Expense
Other Expense7,3283,439(4,057)6,5184,524(732.00)4,8312,755
Pretax Income29,97440,63418,8891,2507,4283,44316,8487,361
Tax Provision1,267(515.00)(248.00)2,230381.00(1,670)1,6931,627
Net Income (Loss)28,70741,14919,137(980.00)7,0475,11315,1555,734
Earnings Per Share (Basic)0.360.520.24(0.01)0.090.070.200.07
Earnings Per Share (Diluted)0.350.510.24(0.01)0.090.070.190.07
Weighted Average Shares Outstanding (Basic)79,53778,58478,72578,39278,02876,48577,01476,538
Weighted Average Shares Outstanding (Diluted)81,31480,57379,69278,39280,05678,16378,46577,163

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VCYT

Veracyte, Inc. (NASDAQ: VCYT) is a stock listed on the Nasdaq Stock Market under the ticker symbol VCYT. It last traded at $25.57 (Nov 18, 2026, 4:00 PM ET), up 5.5% on the day. That gives Veracyte a market capitalisation of $1.9B and a price-to-earnings ratio of 16.4.

Over the past 52 weeks VCYT has traded between $21.91 and $60.91.

Revenue for the quarter ended Mar 31, 2026 was $139.1M; net income $28.7M. Revenue was up 21.5% from $114.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$139.1M$28.7M20.6%
Dec 31, 2025$140.6M$41.1M29.3%
Sep 30, 2025$131.9M$19.1M14.5%
Jun 30, 2025$130.2M-$980.0K-0.8%

From Veracyte’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…